CINECA IRIS Institutional Research Information System

TANDOI, FRANCESCO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 4.525
EU - Europa 2.400
AS - Asia 1.589
SA - Sud America 88
AF - Africa 77
OC - Oceania 32
Continente sconosciuto - Info sul continente non disponibili 9
Totale 8.720
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.461
CN - Cina 1.049
IT - Italia 591
IE - Irlanda 310
SE - Svezia 288
FR - Francia 226
DE - Germania 217
AT - Austria 158
UA - Ucraina 110
FI - Finlandia 97
GB - Regno Unito 96
JP - Giappone 84
VN - Vietnam 74
KR - Corea 73
IN - India 71
DK - Danimarca 56
CA - Canada 51
TW - Taiwan 48
PL - Polonia 47
TR - Turchia 45
BE - Belgio 42
HK - Hong Kong 37
BR - Brasile 34
NL - Olanda 33
ES - Italia 32
AU - Australia 29
SG - Singapore 24
AR - Argentina 22
KE - Kenya 21
RO - Romania 18
RU - Federazione Russa 18
CO - Colombia 17
UZ - Uzbekistan 16
CH - Svizzera 13
PT - Portogallo 13
MX - Messico 10
PH - Filippine 10
ID - Indonesia 9
IR - Iran 9
EG - Egitto 8
EU - Europa 8
TH - Thailandia 8
ZM - Zambia 8
GR - Grecia 7
CZ - Repubblica Ceca 6
PK - Pakistan 6
SA - Arabia Saudita 6
SD - Sudan 6
ZA - Sudafrica 6
BF - Burkina Faso 5
CM - Camerun 5
HR - Croazia 5
IQ - Iraq 5
NO - Norvegia 5
SN - Senegal 5
VE - Venezuela 5
MN - Mongolia 4
CL - Cile 3
CY - Cipro 3
EC - Ecuador 3
ET - Etiopia 3
HU - Ungheria 3
MY - Malesia 3
MZ - Mozambico 3
NZ - Nuova Zelanda 3
PE - Perù 3
BG - Bulgaria 2
CR - Costa Rica 2
GM - Gambi 2
MK - Macedonia 2
NG - Nigeria 2
A1 - Anonimo 1
AE - Emirati Arabi Uniti 1
BY - Bielorussia 1
CU - Cuba 1
EE - Estonia 1
IL - Israele 1
JO - Giordania 1
LB - Libano 1
LU - Lussemburgo 1
NA - Namibia 1
PS - Palestinian Territory 1
SI - Slovenia 1
SK - Slovacchia (Repubblica Slovacca) 1
TN - Tunisia 1
UG - Uganda 1
UY - Uruguay 1
Totale 8.720
Salva come PNG Salva come JPEG
Città #
Chandler 751
Beijing 451
Ann Arbor 322
Dublin 307
Fairfield 285
Houston 284
Ashburn 172
Woodbridge 161
Vienna 154
Nyköping 149
Villeurbanne 145
Dearborn 137
Torino 137
Wilmington 133
Redwood City 124
Princeton 103
Medford 100
Jacksonville 85
Shanghai 84
Cambridge 82
Fremont 75
Turin 69
New York 65
Seattle 61
Guangzhou 57
Pisa 50
Hangzhou 42
Nanjing 39
Warsaw 37
Dong Ket 33
Milan 33
Chengdu 32
Wuhan 30
Boston 29
Tokyo 24
Brussels 23
Rome 21
Taipei 20
Paris 19
San Diego 19
Boardman 18
Singapore 18
Chongqing 17
Seoul 16
Central 15
Kunming 14
London 14
Washington 14
Zhengzhou 14
Changchun 13
Hanoi 13
Hebei 13
Ottawa 13
San Mateo 13
Buenos Aires 12
Melbourne 12
Norwalk 12
Berlin 11
Hefei 11
Leawood 11
Los Angeles 11
Toronto 11
San Francisco 10
Tianjin 10
Bucharest 9
Guiyang 9
Hong Kong 9
Istanbul 9
Nanchang 9
Upper Marlboro 9
Fuzhou 8
Jakarta 8
Mumbai 8
New Delhi 8
Silver Spring 8
Atlanta 7
Bari 7
Hyderabad 7
Jinan 7
Naples 7
Valdagno 7
Ankara 6
Düsseldorf 6
Frankfurt am Main 6
Heidelberg 6
Helsinki 6
Izmir 6
Jiaxing 6
Malatya 6
Málaga 6
Rochester 6
Bangkok 5
Barcelona 5
Changsha 5
Friedrichsdorf 5
Madrid 5
Marsciano 5
Nelson 5
Polska 5
Porto 5
Totale 5.501
Salva come PNG Salva come JPEG
Nome #
Quantitation of HBV cccDNA in anti-HBc-positive liver donors by droplet digital PCR: A new tool to detect occult infection 946
Early introduction of subcutaneous hepatitis B immunoglobulin following liver transplantation for hepatitis B virus infection: A prospective, multicenter study 372
Simultaneous Liver-Kidney Transplantation in Adults: A Single-center Experience Comparing Results with Isolated Liver Transplantation 318
Impact of viral eradication with sofosbuvir-based therapy on the outcome of post-transplant hepatitis C with severe fibrosis 301
Prediction of occult hepatitis B virus infection in liver transplant donors through hepatitis B virus blood markers. 258
Favorable short-term outcome of hepatitis C virus–positive liver graft with bridging fibrosis: A plea for very early viral eradication 231
A Bayesian methodology to improve prediction of early graft loss after liver transplantation derived from the Liver Match study 227
Successful Sequential Liver and Hematopoietic Stem Cell Transplantation in a Child with CD40 Ligand Deficiency and Cryptosporidium -Induced Liver Cirrhosis 194
Liver transplantation for symptomatic centrohepatic biliary cystadenoma 189
Minimization of anti-hepatitis B surface antigen immunoglobulins for prophylaxis of hepatitis B viral recurrence in the first month after liver transplantation: the meaning of HBsAg quantitative level at the time of transplant 187
Donor CYP3A5 genotype influences tacrolimus disposition on the first day after paediatric liver transplantation 162
RANK OF SURVIVAL BENEFIT, AS A PROPOSED PRIORITY SYSTEM, IN LIVER TRANSPLANT WAITING LIST: EVIDENCES FROM AN ITALIAN MULTICENTRE COHORT STUDY 151
Can the Rank of Survival Benefit Be Used as a Priority Allocation System in an European Liver Transplant Waiting List? Evidences from an Italian Multicentre Cohort Study 151
Early reduced liver graft survival in hepatitis C recipients identified by two combined genetic markers 145
Analytical and clinical evaluation of a novel assay for anti-HBc IgG measurement in serum of subjects with overt and occult HBV infection 145
SOFOSBUVIR PLUS RIBAVIRIN IN PATIENTS WITH SEVERE HCV RECURRENCE AFTER LIVER TRANSPLANTATION: A SINGLE CENTRE EXPERIENCE 115
Intrahepatic Administration of Human Liver Stem Cells in Infants with Inherited Neonatal-Onset Hyperammonemia: A Phase I Study 113
Hypothermic Oxygenated Machine Perfusion of Liver Grafts from Brain-Dead Donors 109
Negativization of viremia prior to liver transplant reduces early allograft dysfunction in hepatitis C recipients 103
Carbapenemase Producing Klebsiella Pneumoniae Infection in Liver Transplant Recipients: Review of Our Experience 100
Prognostic Role of Serum Cytokeratin-19 Fragment (CYFRA 21-1) in Patients with Hepatocellular Carcinoma 100
The clinical role of serum epidermal growth factor receptor 3 in hepatitis c virus-infected patients with early hepatocellular carcinoma 100
FEASIBILITY AND EFFICACY OF SOFOSBUVIR-BASED ANTIVIRAL THERAPY BEFORE LIVER TRANSPLANTATION TO PREVENT HCV RECURRENCE: A MONOCENTRIC EXPERIENCE 99
SOFOSBUVIR PLUS RIBAVIRIN BEFORE OR ACROSS LIVER TRANSPLANTATION TO PREVENT HCV RECURRENCE: A SINGLE CENTRE EXPERIENCE 99
Peri-hepatic gauze packing for the control of haemorrhage during liver transplantation: A retrospective study 98
The effect of D-MELD on graft survival and course of HCV recurrence in HCV-RNA positive recipients after liver transplantation 96
Transplantation of the liver from a HBcAb positive donor into a HCV-RNA positive recipient adversely affects graft survival and worsens the course of HCV recurrence 94
“U-shaped” mesoportal jump graft to manage portal vein thrombosis during liver transplantation: A case report 94
Combined liver kidney transplantation for primary hyperoxaluria type 1: Will there still be a future? Current transplantation strategies and monocentric experience 94
SOFOSBUVIR PLUS RIBAVIRIN FOR THE TREATMENT OF SEVERE HCV RECURRENCE AFTER LIVER TRANSPLANTATION: PRELIMINARY DATA FROM A SINGLE-CENTRE EXPERIENCE 93
Alpha-Fetoprotein, Protein Induced by Vitamin K Absence or Antagonist II and Glypican-3 for the Detection and Prediction of Hepatocellular Carcinoma in Patients with Cirrhosis of Viral Etiology 93
Characterization of a novel chemiluminescent enzyme immunoassay for the quantitation of antibodies to hepatitis B core antigen class IgG and correlation with intrahepatic HBV covalently-closed-circular DNA 91
NBAS mutations cause acute liver failure: When acetaminophen is not a culprit 90
Serological characterization of occult HBV infection in liver donors 86
ANTIVIRAL THERAPY WITH SOFOSBUVIR PLUS RIBAVIRIN IN HCV-INFECTED CIRRHOTIC PATIENTS AWAITING LIVER TRANSPLANTATION: PRELIMINARY DATA FROM A SINGLE-CENTRE EXPERIENCE 84
Role of hepatitis B core-related antigen and antibodies to hepatitis B core antigen level in the natural history of chronic HBV infection 84
Carrying on with liver transplantation during the COVID-19 emergency: Report from Piedmont region 84
Peritoneal leukocytoclastic vasculitis as a cause of unexplained persistent ascites after liver transplantation 82
ONCE-DAILY PROLONGED-RELEASE TACROLIMUS IN DE-NOVO LIVER TRANSPLANTATION: A CASE MATCH ANALYSIS WITH TWICE-DAILY TACROLIMUS FORMULATION 82
LIVER GRAFT ISCHEMIC PRECONDITIONING: CLINICAL OUTCOMES 3 YEARS AFTER TRANSPLANTATION 81
SAFETY AND EFFICACY OF SOFOSBUVIR-BASED ANTIVIRAL THERAPY IMMEDIATELY AFTER LIVER TRANSPLANTATION: A MATCHED CASE-CONTROL ANALYSIS 81
DOES CROSSMATCH IMPACT LIVER TRANSPLANTATION OUTCOME? A SINGLE CENTER EXPERIENCE 78
HCV infection and HLA-DRB1*11 in liver transplantation: a 15 years marriage 77
IMMUNOGENETIC FACTORS AFFECT SURVIVAL IN HCV-INFECTED LIVER TRANSPLANT RECIPIENTS 77
Liver transplantation for patients with HCV-related end-stage liver disease and undetectable HCV-RNA: the Turin Centre experience 74
Long term follow-up of arterial infrarenal conduit in liver transplantation 73
ANTIVIRAL THERAPY WITH SOFOSBUVIR PLUS RIBAVIRIN FOR THE TREATMENT OF SEVERE HCV RECURRENCE AFTER LIVER TRANSPLANTATION: PRELIMINARY DATA FROM A SINGLE-CENTRE EXPERIENCE 73
RELATIONSHIP BETWEEN LIVER GRAFT STEATOSIS, VIRAL RECURRENCE AND POST-LIVER TRANSPLANTATION SURVIVAL IN HEPATITIS C VIRUS POSITIVE RECIPIENTS 72
Outcomes of Liver Transplantation in Simultaneously Hepatitis BSurface Antigen and Hepatitis C Virus RNA Positive Recipients: TheDeleterious Effect of Donor Hepatitis B Core Antibody Positivity 70
Once-Daily Prolonged-Release Tacrolimus Versus Twice-Daily Tacrolimus in De-Novo Liver Transplantation 69
Does the Combination between HCV, Presence of Hepatocarcinoma and MELD Influence the Outcome of Liver Transplantation? 68
Mycophenolate monotherapy in Liver Transplantation: Safety and efficacy in 152 patients 68
USE OF GRAFTS FROM HEPATITIS C VIRUS POSITIVE DONORS IN LIVER TRANSPLANTATION: OUTCOMES UNDER CURRENT SELECTION CRITERIA 68
Prolonged Release Tacrolimus in De-Novo Liver Transplantation: A Single Centre Experience 68
First UHPLC MS/MS method coupled with automated on-line SPE for quantification both of tacrolimus and everolimus in peripheral blood mononuclear cells and its application on samples from co-treated pediatric patients 67
Outcomes of Liver Transplantation from Hepatitis B CoreAntibody–Positive Donors in Viral Cirrhosis Patients: The PrevailingNegative Effect of Recipient Hepatitis C Virus Infection 64
Outcome of COVID-19 in liver transplant recipients: A preliminary report from Northwestern Italy 64
Early impact of donor CYP3A5 genotype and Graft-to-Recipient Weight Ratio on tacrolimus pharmacokinetics in pediatric liver transplant patients 64
Two Combined Genetic Markers Identify Hepatitis C Recipients With a Lower Graft Survival From The Earliest Post-Transplant Period 63
Liver transplantation for hepatitis B with delta coinfection: a single center experience 63
Liver transplantation from active COVID-19 donors: A lifesaving opportunity worth grasping? 63
Survey of neonatal respiratory care and surfactant administration in very preterm infants in the Italian Neonatal Network. 62
HCV viremic donors with hepatic bridging fibrosis: Are we ready to use their livers in the era of direct-acting antivirals? 61
HBV cccDNA evaluation in HBV-core antibody (HBcAb)-positive liver transplant donors 60
UHPLC-MS/MS Method with On-line SPE to Quantify Tacrolimus and Everolimus in Peripheral Blood Mononuclear Cells: Application of “IS-normalized” Matrix Effect 58
Use of Hepatitis B Core Antibody Positive Donors in Liver Transplantation: Outcomes in HBV Negative Recipients 57
Excluded segmental duct bile leakage: the case for bilio-enteric anastomosis 57
SOFOSBUVIR PLUS RIBAVIRIN IN HCV-INFECTED CIRRHOTIC PATIENTS AWAITING LIVER TRANSPLANTATION: PRELIMINARY DATA FROM A SINGLE-CENTRE EXPERIENCE 57
The hepatitis D virus in Italy. A vanishing infection, not yet a vanished disease 56
Efficacy and safety profile of Mycophenolate on 1543 liver transplantations 55
Influence of Immunogenetic Donor and Recipient Factors on the Outcome of Liver Transplantation for Hepatits C Virus-Related Chirrosis 55
Transient elastography for non-invasive evaluation of post-transplant liver graft fibrosis in children 55
Liver transplantation with an uncommon full right hemiliver graft after hydatid cysts resection: Case report and review of the literature 55
Role of hepatitis B core-related antigen and antibodies to hepatitis B core antigen levels in the natural history of chronic HBV infection 52
Liver transplantation for hepatocellular carcinoma within Milan criteria in patients with Model for End-stage Liver Disease score below 15: the impact of the etiology of cirrhosis on long-term survival. 49
Differential Intraoperative Effect of Liver Transplant in Different Inborn Errors of Metabolism 49
A simplified regimen of targeted antifungal prophylaxis in liver transplant recipients: a single-center experience 49
Excellent outcomes of liver transplantation using severely steatotic grafts from brain-dead donors 47
Severe Passenger Lymphocyte Syndrome and Acute Rejection in ABO Compatible but non-Identical Liver Transplant Recipient from Hepatitis C Viremic Donor 46
Evaluation of Graft Fibrosis, Inflammation and Donor-specific Antibodies at Protocol Liver Biopsies in Pediatric Liver Transplant Patients: a Single Center Experience 43
RS12989760 POLYMORPHISM OF INTERLEUKIN 28B AND THE OUTCOME OF LIVER TRANSPLANTATION IN HCV-INFECTED PATIENTS 42
Use of Dual Hypothermic Oxygenated Machine Perfusion to Recover Extended Criteria Pediatric Liver Grafts 42
Outcome of liver transplantation with grafts from brain-dead donors treated with dual hypothermic oxygenated machine perfusion, with particular reference to elderly donors 41
Monitoring Tacrolimus Concentrations in Whole Blood and Peripheral Blood Mononuclear Cells: Inter- and Intra-Patient Variability in a Cohort of Pediatric Patients 36
Three-Dimensional Printing in Pediatric Living Donor Liver Transplantation Planning 34
Survey of neonatal respiratory support use in very preterm infants in Italy 33
Quantitation of anti-HBe antibodies in anti-HBc-positive liver donors 28
Combined liver and hematopoietic stem cell transplantation in patients with X-linked hyper-IgM syndrome 14
Early post-liver transplant use of direct-acting antivirals in naive and NS5A inhibitor-experienced HCV patients 13
Development of a Risk Prediction Model for Carbapenem-resistant Enterobacteriaceae Infection after Liver Transplantation: A Multinational Cohort Study 11
Liver Transplantation in Hepatitis B/Hepatitis D (Delta) Virus Coinfected Recipients 9
First report of a gallbladder hemangioma coexisting with gallstones: a case report and literature review of a rare finding 8
Portal vein thrombosis and liver transplantation: management, matching, and outcomes: a retrospective multicenter cohort study 5
Viability assessment and transplantation of fatty liver grafts using end-ischemic normothermic machine perfusion 5
Bacterial and Viral Infections in Liver Transplantation: New Insights from Clinical and Surgical Perspectives 4
Impact of MELD 30-allocation policy on liver transplant outcomes in Italy 3
The Italian data on SARS-CoV-2 infection in transplanted patients support an organ specific immune response in liver recipients 2
Validation of the INCREMENT-SOT-CPE score in a large cohort of liver transplant recipients with carbapenem-resistant Enterobacterales infection 2
Splenic Vessels as a Rescue for Pediatric Kidney Retransplantation in Children With Iliac-caval Agenesis or Thrombosis 2
Totale 9.162
Salva come PNG Salva come JPEG
Categoria #
all - tutte 24.383
article - articoli 0
book - libri 0
conference - conferenze 8.884
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 33.267
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019216 0 0 0 0 0 0 0 0 0 0 124 92
2019/20201.372 61 44 48 122 107 286 145 103 121 140 101 94
2020/20211.186 105 78 63 68 101 100 109 129 107 104 91 131
2021/20221.462 63 64 81 100 106 125 107 98 56 122 299 241
2022/20232.016 206 194 70 196 149 459 133 149 194 49 135 82
2023/2024837 152 160 51 64 62 150 52 41 15 54 36 0
Totale 9.162